2025 North America Automation In Biopharmaceutical Market Revenue Opportunities Report
Description
The 2025 North America Automation In Biopharmaceutical Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automation in Biopharmaceutical Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automation in Biopharmaceutical Market in North America are McKesson Corporation, Omnicell, Inc., ARxIUM, Inc., and Becton, Dickinson and Company (BD). McKesson, headquartered in Texas, is a leading pharmaceutical distribution company offering comprehensive pharmacy automation solutions, including medication management systems and central fill pharmacy automation to improve workflow efficiency and reduce errors. Omnicell, based in California, leads in medication management and robotic dispensing systems; it has recently enhanced its Central Pharmacy Dispensing Service to improve clinical outcomes and labor efficiency across North American health systems. ARxIUM, a U.S.-based company, specializes in providing innovative automation and inventory management solutions for pharmacies, helping streamline pharmacy workflows and optimize drug delivery efficiency. BD has expanded its reach through the acquisition of Parata Systems and development of automated dispensing cabinets (ADC), focusing on improving medication management workflows and safety in hospital and retail pharmacies across North America.
These companies dominate the North American automation market by incorporating technologies such as robotic dispensing, advanced pharmacy software, and integrated systems for workflow optimization. Their solutions aim to address labor shortages, enhance patient safety, reduce medication errors, and support compliance with regulatory standards. Through strategic initiatives and partnerships with hospital networks and pharmacy chains, these firms continuously innovate to adapt to the evolving biopharmaceutical automation landscape driven by growing demand for efficiency and automation in pharmacy operations.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Automation in Biopharmaceutical Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Automation in Biopharmaceutical Market in North America are McKesson Corporation, Omnicell, Inc., ARxIUM, Inc., and Becton, Dickinson and Company (BD). McKesson, headquartered in Texas, is a leading pharmaceutical distribution company offering comprehensive pharmacy automation solutions, including medication management systems and central fill pharmacy automation to improve workflow efficiency and reduce errors. Omnicell, based in California, leads in medication management and robotic dispensing systems; it has recently enhanced its Central Pharmacy Dispensing Service to improve clinical outcomes and labor efficiency across North American health systems. ARxIUM, a U.S.-based company, specializes in providing innovative automation and inventory management solutions for pharmacies, helping streamline pharmacy workflows and optimize drug delivery efficiency. BD has expanded its reach through the acquisition of Parata Systems and development of automated dispensing cabinets (ADC), focusing on improving medication management workflows and safety in hospital and retail pharmacies across North America.
These companies dominate the North American automation market by incorporating technologies such as robotic dispensing, advanced pharmacy software, and integrated systems for workflow optimization. Their solutions aim to address labor shortages, enhance patient safety, reduce medication errors, and support compliance with regulatory standards. Through strategic initiatives and partnerships with hospital networks and pharmacy chains, these firms continuously innovate to adapt to the evolving biopharmaceutical automation landscape driven by growing demand for efficiency and automation in pharmacy operations.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
